West Pharmaceutical Services Inc
WST· NYSE
Released Apr 28, 2022, before the open
10-Q filed Apr 28, 2022, 28 days after period end · 0000105770-22-000017
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $720.00M | $670.70M | $491.50M | $443.50M |
| Net Income | $173.80M | $151.20M | $74.30M | $55.40M |
| EPS Diluted |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $2.29 |
| $1.99 |
| $0.99 |
| $0.73 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.